These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10832486)

  • 1. Measles control in Israel: a decade of the two-dose policy.
    Slater PE; Anis E; Leventhal A
    Public Health Rev; 1999; 27(1-3):235-41. PubMed ID: 10832486
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Two-dose measles immunization as a strategy to eliminate measles in the Middle East and Israel.
    Belmaker I; Bazarsky E; Dukhan L; Shlomo C; Rager-Zisman B
    Isr Med Assoc J; 2008; 10(8-9):640-5. PubMed ID: 18847169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles control in developing and developed countries: the case for a two-dose policy.
    Tulchinsky TH; Ginsberg GM; Abed Y; Angeles MT; Akukwe C; Bonn J
    Bull World Health Organ; 1993; 71(1):93-103. PubMed ID: 8440043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles epidemiology and elimination strategies in Turkey.
    Güriş D; Bayazit Y; Ozdemirer U; Buyurgan V; Yalniz C; Toprak I; Aycan S
    J Infect Dis; 2003 May; 187 Suppl 1():S230-4. PubMed ID: 12721918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The 1991 measles epidemic in Israel.
    Slater PE; Roitman M; Costin C
    Public Health Rev; 1992-1993; 20(1-2):41-51. PubMed ID: 1305976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measles epidemic in Israel-successful containment in the military.
    Gdalevich M; Ephros M; Mimouni D; Grotto I; Shpilberg O; Eldad A; Ashkenazi I
    Prev Med; 2000 Dec; 31(6):649-51. PubMed ID: 11133330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Closer to the goal: efforts in measles elimination in Germany 2010.
    Siedler A; Mankertz A; Feil F; Ahlemeyer G; Hornig A; Kirchner M; Beyrer K; Dreesman J; Scharkus S; Marcic A; Reiter S; Matysiak-Klose D; Santibanez S; Krause G; Wichmann O
    J Infect Dis; 2011 Jul; 204 Suppl 1():S373-80. PubMed ID: 21666187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measles immunization: early two-doses policy experience.
    al-Mazrou YY; al-Jeffri M; Ahmed OM; Aziz KM; Mishkas AH
    J Trop Pediatr; 1999 Apr; 45(2):98-104. PubMed ID: 10341504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measles outbreaks and progress toward measles preelimination --- African region, 2009-2010.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Apr; 60(12):374-8. PubMed ID: 21451448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rehabilitation of the expanded programme on immunization in Sudan following a poliomyelitis outbreak.
    ElZein HA; Birmingham ME; Karrar ZA; Elhassan AA; Omer A
    Bull World Health Organ; 1998; 76(4):335-41. PubMed ID: 9803584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. South-East Asia Regional update on measles mortality reduction and elimination, 2003-2008.
    O'Connor PM; Liyanage JB; Mach O; Anand A; Ramamurty N; Balakrishnan MR; Singh S
    J Infect Dis; 2011 Jul; 204 Suppl 1():S396-402. PubMed ID: 21666190
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Introduction of a second dose of measles in national immunization program in India: a major step towards eradication.
    Verma R; Khanna P; Bairwa M; Chawla S; Prinja S; Rajput M
    Hum Vaccin; 2011 Oct; 7(10):1109-11. PubMed ID: 22238787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progress toward measles elimination--European Region, 2005--2008.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Feb; 58(6):142-5. PubMed ID: 19229166
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measles containment in Israel.
    Slater PE
    Isr J Med Sci; 1991 Jan; 27(1):19-21. PubMed ID: 1995495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evolution of measles elimination strategies in the United States.
    Hinman AR; Orenstein WA; Papania MJ
    J Infect Dis; 2004 May; 189 Suppl 1():S17-22. PubMed ID: 15106084
    [TBL] [Abstract][Full Text] [Related]  

  • 17. International measles incidence and immunization coverage.
    Hall R; Jolley D
    J Infect Dis; 2011 Jul; 204 Suppl 1():S158-63. PubMed ID: 21666157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program.
    Peltola H; Heinonen OP; Valle M; Paunio M; Virtanen M; Karanko V; Cantell K
    N Engl J Med; 1994 Nov; 331(21):1397-402. PubMed ID: 7969278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress toward measles elimination in Germany.
    Hellenbrand W; Siedler A; Tischer A; Meyer C; Reiter S; Rasch G; Teichmann D; Santibanez S; Altmann D; Claus H; Kramer M
    J Infect Dis; 2003 May; 187 Suppl 1():S208-16. PubMed ID: 12721915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Measles control in Sub-Saharan Africa: South Africa as a case study.
    Verguet S; Jassat W; Hedberg C; Tollman S; Jamison DT; Hofman KJ
    Vaccine; 2012 Feb; 30(9):1594-600. PubMed ID: 22230581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.